Dressler Syndrome: A Comprehensive Overview
Definition and Core Concept
Dressler syndrome is a form of late post-myocardial infarction pericarditis that represents an immune-mediated inflammatory response occurring typically 1-2 weeks after myocardial infarction, though it has become remarkably rare (<1%) in the modern era of primary percutaneous coronary intervention 1.
This condition falls under the broader umbrella of post-cardiac injury syndromes (PCIS), which also includes post-pericardiotomy syndrome and post-traumatic pericarditis 1.
Pathogenesis: The Autoimmune Mechanism
The pathophysiology centers on an autoimmune response triggered by initial cardiac tissue damage:
- Myocardial necrosis releases cardiac antigens that trigger an immune response against pericardial and pleural tissues 1
- The latent period of several weeks before symptom onset supports this immune-mediated mechanism 1
- Pericardial bleeding (even minor) into the pericardium serves as a key trigger 1
- The syndrome responds characteristically to anti-inflammatory drugs (NSAIDs, corticosteroids, colchicine) with potential for recurrences 1
Why It's Now Rare
Early reperfusion therapy with primary PCI has dramatically reduced the incidence by limiting infarct size and preventing the extensive myocardial necrosis that triggers the autoimmune cascade 1. When it does occur, it typically reflects larger infarct size and/or late or failed reperfusion 1.
Clinical Features: What to Look For
Diagnosis requires at least 2 of 5 criteria 1:
- Fever without alternative causes
- Pericarditic or pleuritic chest pain (sharp, positional, worse with inspiration)
- Pericardial or pleural friction rubs on auscultation
- Pericardial effusion on imaging
- Pleural effusion with elevated CRP (demonstrating inflammatory activity)
Key Distinguishing Features
- Timing: Occurs 1-2 weeks post-MI (can extend to 6 weeks or even months in rare cases) 1, 2
- Pleuropericardial involvement: Unlike simple pericarditis, often includes pleural effusions and possible pulmonary infiltrates 1
- Inflammatory markers: Elevated CRP is essential to distinguish from mechanical post-surgical effusions 1
Critical Pitfall to Avoid
Do not confuse Dressler syndrome with early post-infarction pericarditis, which occurs within days of MI and is directly related to transmural infarction rather than immune-mediated inflammation 1. Early pericarditis is more common but typically self-limited and transient.
Diagnostic Workup: The Algorithmic Approach
Basic evaluation includes 1:
- Physical examination: Listen for friction rubs, assess for signs of tamponade
- ECG: Look for diffuse ST elevation with PR depression (though often overshadowed by MI changes) 1
- Echocardiography: Essential to detect pericardial effusion and assess hemodynamic significance
- Critical threshold: Effusions >10mm require investigation for possible subacute rupture 1
- Chest X-ray or thoracic ultrasound: Evaluate for pleural effusion
- Inflammatory markers: CRP elevation confirms active inflammation 1
Advanced imaging: Cardiac MRI can demonstrate pericardial inflammation when diagnosis is uncertain 1.
Treatment: Evidence-Based Management
The same therapeutic approach used for acute pericarditis is effective for Dressler syndrome 1:
First-Line Therapy
Aspirin plus colchicine is the recommended combination for symptomatic patients 1:
- Aspirin: Up to 1.5 g/day (antiplatelet effects demonstrated at this dose) 1
- Colchicine: Standard dosing (typically 0.5 mg daily or twice daily)
Important Treatment Considerations
In patients with recent coronary stenting, there are legitimate concerns about high-dose aspirin regarding bleeding and thrombotic risks 3. In such cases, combination therapy with low-dose colchicine and acetaminophen (2000 mg/day) represents a reasonable alternative 3.
Most cases are self-limited and require only supportive care 1. However, persistent symptoms warrant anti-inflammatory therapy to improve remission rates and reduce recurrence risk 1.
What NOT to Do
- NSAIDs are generally not indicated for asymptomatic post-surgical effusions and may increase side effects 1
- Colchicine is not recommended for postoperative effusions in the absence of systemic inflammation 1
- Avoid anticoagulation if possible, as pericardial effusion is often bloody in this setting
Prognosis and Complications
The prognosis is generally good 1:
- In-hospital and 1-year mortality are similar to patients without pericarditis
- Complication rates are low: <4% recurrences, <2% cardiac tamponade
- Constrictive pericarditis develops in approximately 3% of cases 1
Timely primary PCI reduces occurrence and early post-AMI pericarditis remains a marker of larger infarct size but without independent prognostic significance 1.
Monitoring for Tamponade
Echocardiography is recommended when iatrogenic complications are suspected after cardiovascular interventions 1. Watch for hemodynamic compromise requiring urgent pericardiocentesis or surgical drainage.
Clinical Pearls
- Think Dressler syndrome when a post-MI patient develops fever, pleuritic chest pain, and elevated inflammatory markers 1-6 weeks after the event
- The latency period is key: Immediate post-MI pericarditis is different pathophysiologically
- Demonstration of inflammatory activity is essential to establish diagnosis and distinguish from mechanical fluid collections 1
- Response to anti-inflammatory therapy supports the diagnosis and guides management
- Recurrences are possible, so patient education about symptom recognition is important